CancerX shared on LinkedIn:
“Most founders can tell you the moment building the product stopped being the hardest part.
Meet Oggie Nikolic, CEO & Founder of Lind, one of the startups building inside the CancerX community. He shares what the journey has looked like, in his own words.
That’s what the Accelerator is designed for:
- Honest feedback on your idea from clinicians, partners and patient advocates
- Introductions that open doors to pilots, projects and partnerships
- All in service of one mission: reducing cancer mortality by 50% by 2047.
If you’re building in oncology, join us.
Applications for the CancerX Accelerator Cohort 2027 close November 30.
Proceed to the video attached to the post.
Other articles about CancerX on OncoDaily.